Opportunity Information: Apply for RFA CA 22 021

The National Institutes of Health, through the National Cancer Institute (NCI), released this Funding Opportunity Announcement (FOA) to support exploratory and developmental research projects under the R21 mechanism focused on creating genuinely new informatics methods and algorithms for cancer research and management. The opportunity sits within NCI's Informatics Technology for Cancer Research (ITCR) Program, which is aimed at building cutting-edge computational capabilities that can noticeably speed up or strengthen cancer research. The central idea is to fund early-stage, high-innovation work that may be somewhat higher-risk but could deliver major payoffs if successful, especially where new computational approaches remove bottlenecks in how cancer data are handled and understood.

This FOA is specifically looking for innovations in informatics that improve how cancer-related data are acquired, analyzed, visualized, or interpreted. The scope is intentionally broad across the cancer research continuum, including (but not limited to) cancer biology, treatment and diagnosis, early detection, risk assessment and prevention, cancer control and epidemiology, and efforts that address cancer health disparities. In practical terms, an application might propose a new algorithmic approach for integrating complex multi-modal datasets, a novel analytical method that improves inference or prediction from noisy clinical or molecular data, a visualization strategy that helps researchers or clinicians explore high-dimensional cancer datasets more effectively, or a new way to interpret or harmonize data generated across different platforms, sites, or populations. Because it is a "Clinical Trial Optional" R21, applicants may propose a clinical trial if it fits the informatics innovation, but it is not required.

A defining requirement is that the informatics contribution itself must be the novelty. The FOA emphasizes a clear and convincing rationale for why the proposed method or algorithm is new, what makes it meaningfully different from existing approaches, and how it would benefit the broader cancer research field. This point is important because the announcement explicitly excludes projects that mainly apply existing informatics tools or standard algorithms to a new biological or clinical question. In other words, if the computational method is already established and the only "new" aspect is the cancer dataset or the scientific question, that proposal is considered non-responsive and will not move forward for review under this solicitation. The expectation is that the funded work advances informatics capabilities in a way that could be reused, extended, or adopted beyond a single narrow study.

In terms of eligibility, the FOA is open to a wide range of organizations. Eligible applicants include various levels of government (state, county, city/township, and special districts), independent school districts, public housing authorities and Indian housing authorities, public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (both 501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses), and small businesses. It also explicitly calls out additional eligible organization types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, regional organizations, eligible federal agencies, U.S. territories or possessions, Indian/Native American tribal governments that are not federally recognized, and non-U.S. (foreign) entities. The listing reflects an intent to encourage broad participation, including institutions and organizations that may be well positioned to contribute to or benefit from informatics advances that address disparities and diverse populations.

Administratively, the opportunity is a discretionary grant with the activity area spanning education and health, and it is associated with multiple CFDA listings (93.393, 93.394, 93.395, 93.396, 93.399). The FOA number is RFA-CA-22-021, and it was created on March 24, 2022, with an original closing date of November 17, 2022. While the provided source data does not specify an award ceiling or the expected number of awards, the main practical takeaway is that this is an R21 exploratory/developmental mechanism aimed at early-stage innovation, where the strongest applications will clearly define the informatics gap, demonstrate why existing methods fall short, and lay out a credible plan to produce a new method or algorithm that can advance cancer research broadly rather than only supporting a single narrow use case.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393, 93.394, 93.395, 93.396, 93.399.
  • This funding opportunity was created on 2022-03-24.
  • Applicants must submit their applications by 2022-11-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA CA 22 021

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Research Program Award (R35 Clinical Trial Optional)

Previous opportunity: Secondary Education, Two-Year Postsecondary Education, and Agriculture in the K-12 Classroom Challenge Grants Program

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 22 021

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 22 021) also looked into and applied for these:

Funding Opportunity
PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed) Apply for RFA CA 22 013

Funding Number: RFA CA 22 013
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Patient Derived Xenograft (PDX) Development and Trial Centers (PDTCs) Network (U54 Clinical Trial Not Allowed) Apply for RFA CA 22 012

Funding Number: RFA CA 22 012
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional) Apply for RFA DA 23 021

Funding Number: RFA DA 23 021
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 025

Funding Number: RFA AI 22 025
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional) Apply for PAR 22 145

Funding Number: PAR 22 145
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional) Apply for RFA CA 22 016

Funding Number: RFA CA 22 016
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $450,000
Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) Apply for RFA CA 22 020

Funding Number: RFA CA 22 020
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $475,000
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 22 025

Funding Number: RFA CA 22 025
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $2,000,000
Increasing Immediate Engagement and Retention in HIV Treatment with Substance Users (R01- Clinical Trials Required) Apply for RFA DA 23 002

Funding Number: RFA DA 23 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) Apply for PAR 22 161

Funding Number: PAR 22 161
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional) Apply for PAR 22 147

Funding Number: PAR 22 147
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $400,000
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Apply for PAR 22 136

Funding Number: PAR 22 136
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional) Apply for PAR 22 131

Funding Number: PAR 22 131
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Limited Interaction Targeted Epidemiology: Viral Suppression (LITE-VS) (UG3/UH3 Clinical Trial Optional) Apply for RFA AI 22 024

Funding Number: RFA AI 22 024
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) Apply for PAR 22 162

Funding Number: PAR 22 162
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed) Apply for PAR 22 153

Funding Number: PAR 22 153
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed) Apply for PAR 22 152

Funding Number: PAR 22 152
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) Apply for PAR 22 151

Funding Number: PAR 22 151
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed) Apply for RFA DA 23 040

Funding Number: RFA DA 23 040
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Pathogenic Mechanisms influencing Blood Brain Barrier function in HIV and Substance Use Disorders (R01 Clinical Trial Optional) Apply for RFA DA 23 012

Funding Number: RFA DA 23 012
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 22 021", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: